Posted by admin on May 21st, 2022
Avantor, Inc. (NYSE:AVTR – Get Rating) has earned an average rating of “Buy” from the nineteen analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $43.60.
Several analysts have recently issued reports on the company. Zacks Investment Research raised Avantor from a “sell” rating to a “hold” rating in a report on Tuesday, May 3rd. Cowen reduced their target price on Avantor from $50.00 to $44.00 in a report on Tuesday, April 19th. William Blair reissued an “outperform” rating on shares of Avantor in a report on Friday, April 29th. Morgan Stanley reduced their target price on Avantor from $46.00 to $43.00 and set an “overweight” rating on the stock in a report on Monday, February 7th. Finally, Robert W. Baird reduced their target price on Avantor from $44.00 to $43.00 in a report on Monday, February 7th.
In other news, EVP Gerard Brophy sold 2,027 shares of the firm’s stock in a transaction dated Tuesday, March 1st. The stock was sold at an average price of $34.47, for a total transaction of $69,870.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by company insiders.
A number of hedge funds have recently modified their holdings of the business. The Manufacturers Life Insurance Company grew its stake in Avantor by 2,120.6% in the first quarter. The Manufacturers Life Insurance Company now owns 231,589 shares of the company’s stock valued at $7,952,000 after acquiring an additional 221,160 shares during the period. Toroso Investments LLC grew its stake in Avantor by 14.5% in the first quarter. Toroso Investments LLC now owns 14,434 shares of the company’s stock valued at $488,000 after acquiring an additional 1,832 shares during the period. BNP Paribas Arbitrage SA grew its stake in Avantor by 19.4% in the first quarter. BNP Paribas Arbitrage SA now owns 137,643 shares of the company’s stock valued at $4,655,000 after acquiring an additional 22,376 shares during the period. Walleye Capital LLC acquired a new stake in Avantor in the first quarter valued at approximately $4,038,000. Finally, Wealthfront Advisers LLC grew its stake in Avantor by 69.6% in the first quarter. Wealthfront Advisers LLC now owns 8,716 shares of the company’s stock valued at $295,000 after acquiring an additional 3,578 shares during the period. Institutional investors and hedge funds own 93.24% of the company’s stock.
AVTR stock opened at $31.22 on Friday. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.80 and a quick ratio of 1.18. The stock has a market capitalization of $19.05 billion, a price-to-earnings ratio of 35.08, a PEG ratio of 0.64 and a beta of 1.53. The business’s fifty day moving average price is $32.02 and its two-hundred day moving average price is $35.71. Avantor has a fifty-two week low of $28.64 and a fifty-two week high of $44.37.
Avantor (NYSE:AVTR – Get Rating) last posted its quarterly earnings data on Thursday, April 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.93 billion. Avantor had a return on equity of 32.17% and a net margin of 7.72%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.35 EPS. Research analysts expect that Avantor will post 1.51 EPS for the current year.
Avantor Company Profile (Get Rating)
Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
Critical Survey: Quantum-Si (QSI) versus Its Competitors
Aptiv PLC (NYSE:APTV) Receives Average Rating of “Buy” from Analysts